Origin Oncology
Oncology
Overview
Origin Oncology has developed a patented MV-IR method for detecting ovarian cancer in Stage I, where patients have av92% five-year survival rate. It was founded in September 2017 by President Matthew Curtis, a law student. The firm is based on the research of Biological Sciences Professor Crislyn D'Souza-Schorey. It participated in the McCloskey Competition.
Founder(s)
Matthew Curtis